NCOA2 is a candidate target gene of 8q gain associated with clinically aggressive prostate cancer

MP Silva, JD Barros‐Silva, J Vieira… - Genes …, 2016 - Wiley Online Library
Prostate carcinomas harboring 8q gains are associated with poor clinical outcome, but the
target genes of this genomic alteration remain to be unveiled. In this study, we aimed to …
被引用次数：19 相关文章

NCOA2 is a candidate target gene of 8q gain associated with clinically aggressive prostate cancer

MP Silva, JD Barros‐Silva, J Vieira, S Lisboa… - Genes, Chromosomes …, 2016 - infona.pl
Prostate carcinomas harboring 8q gains are associated with poor clinical outcome, but the
target genes of this genomic alteration remain to be unveiled. In this study, we aimed to …

NCOA2 is a candidate target gene of 8q gain associated with clinically aggressive prostate cancer

MP Silva, JD Barros-Silva, J Vieira… - Genes …, 2016 - pubmed.ncbi.nlm.nih.gov
Prostate carcinomas harboring 8q gains are associated with poor clinical outcome, but the
target genes of this genomic alteration remain to be unveiled. In this study, we aimed to …

NCOA2 is a candidate target gene of 8q gain associated with clinically aggressive prostate cancer.

MP Silva, JD Barros-Silva, J Vieira… - Genes …, 2016 - europepmc.org
Prostate carcinomas harboring 8q gains are associated with poor clinical outcome, but the
target genes of this genomic alteration remain to be unveiled. In this study, we aimed to …
[PDF] academia.edu

[PDF][PDF] NCOA2 is a Candidate Target Gene of 8q Gain Associated with Clinically Aggressive Prostate Cancer

MP Silva, JD Barros-Silva, J Vieira, S Lisboa… - GENES …, 2016 - academia.edu
Prostate carcinomas harboring 8q gains are associated with poor clinical outcome, but the
target genes of this genomic alteration remain to be unveiled. In this study, we aimed to …